Laurent Arnaud

Active 2000–2025

185
Papers
18,144
Citations
80
h-index
165
i10-index

Citations

Citations per year for Laurent Arnaud1978: 2 citations2000: 1 citations2003: 1 citations2005: 1 citations2006: 7 citations2007: 2 citations2008: 5 citations2009: 10 citations2010: 17 citations2011: 40 citations2012: 42 citations2013: 80 citations2014: 156 citations2015: 170 citations2016: 106 citations2017: 156 citations2018: 105 citations2019: 398 citations2020: 521 citations2021: 581 citations2022: 591 citations2023: 375 citations2024: 866 citations2025: 509 citations2026: 18 citations1979–1999: no citations, so these years are not shown2001–2002: no citations, so these years are not shown2004: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,158 citing papers, 16.4% of this breakdownFrance: 618 citing papers, 8.7% of this breakdownChina: 547 citing papers, 7.7% of this breakdownItaly: 494 citing papers, 7% of this breakdownUnited Kingdom: 462 citing papers, 6.5% of this breakdownGermany: 343 citing papers, 4.8% of this breakdownSpain: 235 citing papers, 3.3% of this breakdownCanada: 230 citing papers, 3.3% of this breakdownNetherlands: 209 citing papers, 3% of this breakdownJapan: 197 citing papers, 2.8% of this breakdownAustralia: 171 citing papers, 2.4% of this breakdownSweden: 170 citing papers, 2.4% of this breakdown
0%16.4%Other 31.7%

Fields

  • Medicine76.8%
  • Biochemistry, Genetics and Molecular Biology9.6%
  • Immunology and Microbiology4.7%
  • Earth and Planetary Sciences2.8%
  • Engineering1.8%
  • Materials Science0.9%
  • Other3.4%

Topics

  • Systemic Lupus Erythematosus Research10.1%
  • Rheumatoid Arthritis Research and Therapies3.6%
  • Systemic Sclerosis and Related Diseases2.5%
  • Histiocytic Disorders and Treatments2.3%
  • T-cell and B-cell Immunology2.2%
  • Extracellular vesicles in disease2.1%
  • Other77.2%

Coauthors

All papers

Open in search
  1. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthias Schneider, Josef S Smolen, Elisabet Svenungsson, Yoshiya Tanaka, Maria G. Tektonidou, Y K Onno Teng, Anǵela Tincani, Edward M Vital, Ronald van Vollenhoven, Chris Wincup, George Βertsias, Dimitrios T. Boumpas - Annals of the Rheumatic Diseases 2023 cited by 933

  2. 2021 DORIS definition of remission in SLE: final recommendations from an international task force

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Raquel Faria, Rebecca S. B. Fischer, Ruth Fritsch‐Stork, Murat İnanç, Søren Jacobsen, David Jayne, Annegret Kuhn, Bernadette van Leeuw, Maarten Limper, Xavier Mariette, Sandra Navarra, Mandana Nikpour, Marzena Olesińska, Guillermo Pons‐Estel, Juanita Romero‐Díaz, Blanca Rubio, Y Schoenfeld, Eloísa Bonfá, Josef S Smolen, Y K Onno Teng, Anǵela Tincani, Michel Tsang-A-Sjoe, Carlos Vasconcelos, Anne Voss, Victoria P. Werth, Elena Zakharhova, Cynthia Aranow - Lupus Science & Medicine 2021 cited by 349

  3. Systemic lupus erythematosus

    Authors: , , , - The Lancet 2024 cited by 327

  4. Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge

    Authors: , , , , - Therapeutic Advances in Musculoskeletal Disease 2022 cited by 194

  5. A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Véronique Le Guern, Kirsten Lerstrøm, Roger A. Levy, Francinne Machado-Ribeiro, Xavier Mariette, Jamil Missaykeh, Eric F. Morand, Marta Mosca, Murat İnanç, Sandra Navarra, Irmgard Neumann, Marzena Olesińska, Michelle Petri, Anisur Rahman, Ole Petter Rekvig, Jozef Rovenský, Yehuda Shoenfeld, Josef S Smolen, Anǵela Tincani, Murray B. Urowitz, Bernadette van Leeuw, Carlos Vasconcelos, Anne Voss, Victoria P. Werth, Elena Zakharova, Asad Zoma, Matthias Schneider, Michael M. Ward - Annals of the Rheumatic Diseases 2016 cited by 357

  6. The world-wide burden of musculoskeletal diseases: a systematic analysis of the World Health Organization Burden of Diseases Database

    Authors: , , , , , - Annals of the Rheumatic Diseases 2019 cited by 369

  7. 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2022 cited by 225

  8. Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014

    Authors: , , , , , , , , , , , , , , , , , , - Autoimmunity Reviews 2020 cited by 153

  9. EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2023 cited by 120

  10. Long-term outcomes in systemic lupus erythematosus: trends over time and major contributors

    Authors: , - Lara D. Veeken 2020 cited by 176

  11. Immunopathogenesis of systemic lupus erythematosus: An update

    Authors: , , - Autoimmunity Reviews 2024 cited by 89

  12. Serious infections in patients with VEXAS syndrome: data from the French VEXAS registry

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , François Lifermann, Maxime Samson, Susann Pechuzal, Achille Aouba, Olivier Kosmider, Jérémie Dion, S. Grosleron, R. Bourguiba, Benjamin Terrier, Sophie Georgin‐Lavialle, O. Fain, A. Mékinian, Marjolaine Morgand, Thibault Comont, Jérôme Hadjadj, Isabelle Melki, Pierre Fenaux, Lionel Adès, A. Audemard, Mikaël Ebbo, Yvan Jamilloux, Odile Beyne Rauzy, Alexandre Bélot, Raphaël Borie, Alexis Mathian, Laurent Arnaud, François Chasset, Jean‐David Bouaziz, Pierre Sujobert, Y. Benhamou, Gaëtan Sauvêtre, Khalil El-Karoui, François Rodrigues - Annals of the Rheumatic Diseases 2023 cited by 71

  13. Dissemination of extreme levels of extracellular vesicles: tissue factor activity in patients with severe COVID-19

    Authors: , , , , , , , , , , , , , , , - Blood Advances 2021 cited by 150

  14. High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Blood 2012 cited by 693

  15. Indolic uremic solutes increase tissue factor production in endothelial cells by the aryl hydrocarbon receptor pathway

    Authors: , , , , , , , , , , , , , , - Kidney International 2013 cited by 237

  16. The Main Challenges in Systemic Lupus Erythematosus: Where Do We Stand?

    Authors: , - Journal of Clinical Medicine 2021 cited by 92

  17. Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: An international and collaborative meta-analysis

    Authors: , , , , , , , , , , , , , - Autoimmunity Reviews 2013 cited by 215

  18. Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , George Βertsias, Ilaria Bini, Anca Bobîrcă, Ware Branch, Antonio Brucato, Irene E. M. Bultink, S. Capela, Irene Cecchi, Ricard Cervera, Cecilia Beatrice Chighizola, Claudia Cobilinschi, María José Cuadrado, Dzifa Dey, Oseme Etomi, Gerard Espinosa, Julia Flint, João-Eurico Fonseca, Ruth Fritsch‐Stork, Maria Gerosa, Bente Glintborg, Carina Gøtestam Skorpen, Bethan Goulden, Christine Graversgaard, Iva Gunnarsson, Latika Gupta, Merete Lund Hetland, Kenneth Hodson, Beverley J. Hunt, David Isenberg, Søren Jacobsen, Munther A. Khamashta, Roger A. Levy, Louise Linde, Jacob Alexander Lykke, Yvette Meißner, Louise Moore, Eric F. Morand, Sandra Navarra, Daniela Opriș-Belinski, Monika Østensen, Hiroki Ozawa, Luis Fernando Pérez-García, Michelle Petri, Guillermo Pons‐Estel, Massimo Radin, Luigi Raio, Amihai Rottenstreich, Guillermo Ruiz‐Irastorza, Slađana Rumpl Tunjić, Marite Rygg, Savino Sciascia, Anja Strangfeld, Elisabet Svenungsson, Maria G. Tektonidou, Anne Troldborg, Évelyne Vinet, Jelena Vojinović, Anne Voss, Marianne Wallenius, Laura Andréoli - The Lancet Rheumatology 2023 cited by 34

  19. Living with systemic lupus erythematosus in 2020: a European patient survey

    Authors: , , , , - Lupus Science & Medicine 2021 cited by 88

  20. Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , B. Faucher, Jean‐David Bouaziz, Jonathan Broner, Cyril Dumain, Carole Antoine, Benjamin Carpentier, Brice Castel, Céline Lartigau-Roussin, Étienne Crickx, Geoffroy Volle, Damien Fayard, Paul Decker, T. Moulinet, Anaël Dumont, Alexandre Nguyen, Achille Aouba, Jean-Philippe Martellosio, M. Levavasseur, S. Puigrenier, Pascale Antoine, Jean-Thomas Giraud, Olivier Hermine, Carole Lacout, Nihal Martis, J.D. Karam, François Chasset, Laurent Arnaud, Paola Marianetti, C. Deligny, Thibaud Chazal, Pascal Woaye-Hune, Murielle Roux-Sauvat, A. Meyer, Pierre Sujobert, Pierre Hirsch, Noémie Abisror, Pierre Fenaux, Olivier Kosmider, Vincent Jachiet, O. Fain, Benjamin Terrier, A. Mékinian, Sophie Georgin‐Lavialle, Sophie Georgin-Lavialle, Isabelle Melki, Lionel Adès, Lin‐Pierre Zhao, A. Audemard, Mikaël Ebbo, Odile Beyne Rauzy, Alexandre Bélot, Raphaël Borie, Y. Benhamou, Gaëtan Sauvêtre, Khalil El Karoui, François Rodrigues, Louis Terriou, Jérémie Dion - Annals of the Rheumatic Diseases 2024 cited by 64

  21. Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease

    Authors: , , , , , , , , , , , , , , , , - Blood 2014 cited by 586

  22. Impact of glucocorticoids on the incidence of lupus-related major organ damage: a systematic literature review and meta-regression analysis of longitudinal observational studies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christine Peschken, Bernardo A. Pons‐Estel, Anisur Rahman, Rosalind Ramsey‐Goldman, John A. Reynolds, Juanita Romero‐Díaz, Guillermo Ruiz‐Irastorza, Jorge Sánchez‐Guerrero, Elisabet Svenungsson, Murray B. Urowitz, Évelyne Vinet, Ronald van Vollenhoven, Alexandre E. Voskuyl, Daniel J. Wallace, Michelle Petri, Susan Manzi, Ann E. Clarke, Mike W.‐L. Cheung, Vernon T. Farewell, Graciela S. Alarcón - Lupus Science & Medicine 2021 cited by 91

  23. Smoking and pre-existing organ damage reduce the efficacy of belimumab in systemic lupus erythematosus

    Authors: , , , , , , , , , , , - Autoimmunity Reviews 2017 cited by 107

  24. 10 most important contemporary challenges in the management of SLE

    Authors: , , , , , , , , , , , , - Lupus Science & Medicine 2019 cited by 78